Institutions continue to employ more “”traditional”" sterile preparation with similar procedures in the operating room. Multiple studies have
also shown no significant difference in postoperative course when preoperative antibiotics are administered for sinus procedures.
Methods: Endoscopic sinus procedures were selected (58 patients) to analyze itemized sterile costs. Drapes, gloves, gowns, and antibiotics, were then tallied and compared to the same items for cochlear implants (14 procedures). The “”sterile-prep”" time was also analyzed and compared between the two procedures. Cost difference was analyzed.
Results: Comparing the supplies used for sinus procedures (56) and cochlear implants, our average sinus cost was $10.19, compared to $34.64, with a difference of $24.45. This equated to a savings STI571 ic50 of $1418.00 in sinus procedure supplies that year. The difference in draping
and scrubbing time showed a difference Epigenetics inhibitor of 20 min between groups, equaling a value of $1760 difference/case. This calculated to a savings of $10,2080 for sinus operating room time. There was no difference in patient outcomes with this surgical preparatory approach.
Conclusion: Our analysis showed a large cost savings over a fiscal year in operative time and supplies. This did not compromise any patient outcomes given the already non-sterile nature of endoscopic sinus surgery. This practice can be adopted to greatly enhance efficiency without sacrificing surgical results. Published by Elsevier Ireland Ltd.”
“To investigate the prevalence of ATPIII- and IDF-defined metabolic syndrome (MetS) in an Irish screening population and to determine the calculated cardiovascular risk for each group.
A total of 1,716 subjects were enrolled over VX-770 a 12-month period.
The ATPIII-defined prevalence of MetS in this population
was 13.2%. Using IDF criteria, 21.4% of subjects were identified as having the MetS. Correlation between the two definitions was high; however, IDF criteria identified an additional 9.5% (n = 164) of the population as having MetS, which ATPIII criteria failed to recognise.
We noted a higher prevalence of MetS in the studied population when defined by IDF criteria. However, those identified by IDF and not by ATPIII definition did not have a higher cardiovascular risk score by either Framingham or European Score than those without MetS. Thus, application of the ATPIII definition of MetS, may be the more practical.”
“Objective: To describe the development and challenges of a pharmacist-directed peer support program among adolescents with diabetes.
Practice description: The program was designed as adjunctive therapy for adolescents receiving care at the Diabetes Education and Research Center (DERC). DERC is an interdisciplinary facility at which the clinical pharmacist provides direct, diabetes-related patient care services.